Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 54.40
-0.90 (-1.63%)
At close: Mar 26, 2026
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.54 billion as of March 26, 2026. Its market cap has decreased by -26.98% in one year.
Market Cap
6.54B
Enterprise Value
8.60B
Revenue
4.85B
Ranking
n/a
PE Ratio
14.95
Stock Price
54.40
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.54B, an increase of 16.83%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 6.54B | -8.26% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YungShin Global Holding | 14.14B |
| Foresee Pharmaceuticals | 12.30B |
| Alar Pharmaceuticals | 11.76B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Handa Pharmaceuticals | 11.00B |
| Orient Pharma | 6.55B |
| SCI Pharmtech | 6.25B |
| LIWANLI Innovation | 5.24B |